Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 7—July 2016

Identification of Streptococcus suis Meningitis through Population-Based Surveillance, Togo, 2010–2014

Haoua Tall, Berthe-Marie Njanpop-Lafourcade, Didier Mounkoro, Loukoumane Tidjani, Kodjo Agbenoko, Issifou Alassani, Moussa Amidou, Stanislas Tamekloe, Kenneth G. Laing, Adam A. Witney, Jason Hinds, Mark P.G. van der Linden, Bradford D. Gessner, and Jennifer C. MoïsiComments to Author 
Author affiliations: Agence de Médecine Préventive, Ouagadougou, Burkina Faso (H. Tall); Agence de Médecine Préventive, Paris, France (B.-M. Njanpop-Lafourcade, B.D. Gessner, J.C. Moïsi); Agence de Médecine Préventive, Dapaong, Togo (D. Mounkoro, L. Tidjani); Ministry of Health, Togo (K. Agbenoko, I. Alassani, M. Amidou, S. Tamekloe); St. George’s, University of London, London, UK (K.G. Laing, A.A. Witney, J. Hinds); RWTH Aachen University, Aachen, Germany (M.P.G. van der Linden)

Main Article

Table 2

Antimicrobial resistance patterns of Streptococcus suis and other Streptococcus spp. isolates from meningitis patients in 2 rural districts in northern Togo, 2010–2014

Antimicrobial drug No. S. suis samples tested/no. (%) susceptible
No. other Streptococcus spp. samples tested/no. (%) susceptible
Tested at local laboratory* Tested at reference laboratory†
Amoxicillin 15/15 (100) 11/10 (91) 9/5 (56)
Cefotaxime 0 11/10 (91) 0
Ceftriaxone 15/15 (100) 0 9/8 (89)
Chloramphenicol 15/12 (80) 11/11 (100) 9/8 (89)
Clindamycin 0 11/10 (91) 0
Cotrimoxazole 15/14 (93) 0 9/6 (67)
Gentamicin 15/7 (47) 0 9/4 (44)
Levofloxacin 0 11/10 (91) 0
Oxacillin 12/3 (25) 11/11 (100) 1/0
Penicillin 15/15 (100) 11/10 (91) 9/5 (56)
Rifampin 15/15 (100) 0 9/6 (67)
Tetracycline 0 11/0 0

*The regional bacteriology laboratory in Dapaong, Togo.
†National Reference Center for Streptococci in Aachen, Germany.

Main Article

Page created: June 14, 2016
Page updated: June 14, 2016
Page reviewed: June 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.